196 related articles for article (PubMed ID: 37194065)
1. Inhibition of discoidin domain receptor (DDR)-1 with nilotinib alters CSF miRNAs and is associated with reduced inflammation and vascular fibrosis in Alzheimer's disease.
Stevenson M; Varghese R; Hebron ML; Liu X; Ratliff N; Smith A; Turner RS; Moussa C
J Neuroinflammation; 2023 May; 20(1):116. PubMed ID: 37194065
[TBL] [Abstract][Full Text] [Related]
2. Alteration of Autophagy and Glial Activity in Nilotinib-Treated Huntington's Disease Patients.
Anderson KE; Stevenson M; Varghese R; Hebron ML; Koppel E; McCartin M; Kuprewicz R; Matar S; Ferrante D; Moussa C
Metabolites; 2022 Dec; 12(12):. PubMed ID: 36557263
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib.
Day E; Waters B; Spiegel K; Alnadaf T; Manley PW; Buchdunger E; Walker C; Jarai G
Eur J Pharmacol; 2008 Dec; 599(1-3):44-53. PubMed ID: 18938156
[TBL] [Abstract][Full Text] [Related]
4. Discoidin Domain Receptor 1 is a therapeutic target for neurodegenerative diseases.
Fowler AJ; Hebron M; Balaraman K; Shi W; Missner AA; Greenzaid JD; Chiu TL; Ullman C; Weatherdon E; Duka V; Torres-Yaghi Y; Pagan FL; Liu X; Ressom H; Ahn J; Wolf C; Moussa C
Hum Mol Genet; 2020 Oct; 29(17):2882-2898. PubMed ID: 32776088
[TBL] [Abstract][Full Text] [Related]
5. Multikinase Abl/DDR/Src Inhibition Produces Optimal Effects for Tyrosine Kinase Inhibition in Neurodegeneration.
Fowler AJ; Hebron M; Missner AA; Wang R; Gao X; Kurd-Misto BT; Liu X; Moussa CE
Drugs R D; 2019 Jun; 19(2):149-166. PubMed ID: 30919310
[TBL] [Abstract][Full Text] [Related]
6. Discoidin domain receptor 1 (DDR1) kinase as target for structure-based drug discovery.
Kothiwale S; Borza CM; Lowe EW; Pozzi A; Meiler J
Drug Discov Today; 2015 Feb; 20(2):255-61. PubMed ID: 25284748
[TBL] [Abstract][Full Text] [Related]
7. Nilotinib, a Discoidin domain receptor 1 (DDR1) inhibitor, induces apoptosis and inhibits migration in breast cancer.
Wang S; Xie Y; Bao A; Li J; Ye T; Yang C; Yu S
Neoplasma; 2021 Sep; 68(5):975-982. PubMed ID: 34263649
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease.
Pagan FL; Hebron ML; Wilmarth B; Torres-Yaghi Y; Lawler A; Mundel EE; Yusuf N; Starr NJ; Arellano J; Howard HH; Peyton M; Matar S; Liu X; Fowler AJ; Schwartz SL; Ahn J; Moussa C
Pharmacol Res Perspect; 2019 Apr; 7(2):e00470. PubMed ID: 30906562
[TBL] [Abstract][Full Text] [Related]
9. PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.
Wang HY; Pei Z; Lee KC; Lopez-Brignoni E; Nikolov B; Crowley CA; Marsman MR; Barbier R; Friedmann N; Burns LH
J Prev Alzheimers Dis; 2020; 7(4):256-264. PubMed ID: 32920628
[TBL] [Abstract][Full Text] [Related]
10. Structural mechanisms determining inhibition of the collagen receptor DDR1 by selective and multi-targeted type II kinase inhibitors.
Canning P; Tan L; Chu K; Lee SW; Gray NS; Bullock AN
J Mol Biol; 2014 Jun; 426(13):2457-70. PubMed ID: 24768818
[TBL] [Abstract][Full Text] [Related]
11. Nilotinib and bosutinib modulate pre-plaque alterations of blood immune markers and neuro-inflammation in Alzheimer's disease models.
Lonskaya I; Hebron ML; Selby ST; Turner RS; Moussa CE
Neuroscience; 2015 Sep; 304():316-27. PubMed ID: 26235435
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of discoidin domain receptors by imatinib prevented pancreatic fibrosis demonstrated in experimental chronic pancreatitis model.
Bansod S; Saifi MA; Godugu C
Sci Rep; 2021 Jun; 11(1):12894. PubMed ID: 34145346
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of DDR1-BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer.
Jeitany M; Leroy C; Tosti P; Lafitte M; Le Guet J; Simon V; Bonenfant D; Robert B; Grillet F; Mollevi C; El Messaoudi S; Otandault A; Canterel-Thouennon L; Busson M; Thierry AR; Martineau P; Pannequin J; Roche S; Sirvent A
EMBO Mol Med; 2018 Apr; 10(4):. PubMed ID: 29438985
[TBL] [Abstract][Full Text] [Related]
14. Nilotinib-induced autophagic changes increase endogenous parkin level and ubiquitination, leading to amyloid clearance.
Lonskaya I; Hebron ML; Desforges NM; Schachter JB; Moussa CE
J Mol Med (Berl); 2014 Apr; 92(4):373-86. PubMed ID: 24337465
[TBL] [Abstract][Full Text] [Related]
15. Collagen I induces discoidin domain receptor (DDR) 1 expression through DDR2 and a JAK2-ERK1/2-mediated mechanism in primary human lung fibroblasts.
Ruiz PA; Jarai G
J Biol Chem; 2011 Apr; 286(15):12912-23. PubMed ID: 21335558
[TBL] [Abstract][Full Text] [Related]
16. Exploring the collagen-binding site of the DDR1 tyrosine kinase receptor.
Abdulhussein R; McFadden C; Fuentes-Prior P; Vogel WF
J Biol Chem; 2004 Jul; 279(30):31462-70. PubMed ID: 15136580
[TBL] [Abstract][Full Text] [Related]
17. Discoidin Domain Receptor 1 Inhibitors: Advances and Future Directions for Novel Therapeutics with Aid of DNA Encoded Library Screens and Artificial Intelligence.
Sanawar R; Sahayasheela VJ; Sarath P; Dan VM
Mini Rev Med Chem; 2023; 23(15):1507-1513. PubMed ID: 36698236
[TBL] [Abstract][Full Text] [Related]
18. CSF MicroRNAs Reveal Impairment of Angiogenesis and Autophagy in Parkinson Disease.
Fowler AJ; Ahn J; Hebron M; Chiu T; Ayoub R; Mulki S; Ressom H; Torres-Yaghi Y; Wilmarth B; Pagan FL; Moussa C
Neurol Genet; 2021 Dec; 7(6):e633. PubMed ID: 34786477
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of collagen binding by the human discoidin domain receptors, DDR1 and DDR2. Identification of collagen binding sites in DDR2.
Leitinger B
J Biol Chem; 2003 May; 278(19):16761-9. PubMed ID: 12611880
[TBL] [Abstract][Full Text] [Related]
20. The tyrosine kinase inhibitor nilotinib targets the discoidin domain receptor DDR2 in calcific aortic valve stenosis.
Carracedo M; Pawelzik SC; Artiach G; Pouwer MG; Plunde O; Saliba-Gustafsson P; Ehrenborg E; Eriksson P; Pieterman E; Stenke L; Princen HMG; Franco-Cereceda A; Bäck M
Br J Pharmacol; 2022 Oct; 179(19):4709-4721. PubMed ID: 35751904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
